Inspire Investing, LLC Cellectis S.A. Transaction History

Inspire Investing, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$8.21 - $21.02 $205 - $525	-25 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$7.81 - $18.82 $195 - $470	25 New	25 $0
Q1 2018 Apr 13, 2018	SELL	$27.78 - $35.19 $1,194 - $1,513	-43 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$23.33 - $35.01 $1,003 - $1,505	43	43 $1,000

11.2M

5.9K

1.4K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $88.3M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.